What is the current coagulation factor ix market size?

The coagulation factor ix market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the coagulation factor ix market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the coagulation factor ix market?

Key drivers include rising hemophilia A cases and advancements in coagulation factor ix products.

What are the major challenges facing the coagulation factor ix market?

Challenges include high treatment costs and limited access to coagulation factor ix products in developing regions.

Which regions are leading the coagulation factor ix market?

North America and Europe are leading the market due to high adoption rates of coagulation factor ix products.

Who are the top companies in the coagulation factor ix market?

Top companies include Pfizer, Novartis, and Biogen, which offer a range of coagulation factor ix products.

What are the future opportunities in the coagulation factor ix market?

Future opportunities include emerging markets and innovative coagulation factor ix products with improved efficacy.

How is technology impacting the coagulation factor ix market?

Technology is advancing coagulation factor ix production, improving product quality and reducing costs.

What is the current regulatory landscape for the coagulation factor ix market?

The regulatory landscape is evolving, with stringent regulations and guidelines for coagulation factor ix product approval.

What is the future outlook for the coagulation factor ix market?

The future outlook is positive, with increasing demand and advancements in coagulation factor ix products driving growth.

coagulation factor ix Growth Trends & Strategic Outlook 2033

coagulation factor ix by Application (Adult, Kids), by Types (Coagulation Factor IX (Plasma Derived), Coagulation Factor IX (Recombinant)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

coagulation factor ix Market Overview

The coagulation factor IX market refers to the industry involved in the development, manufacturing, and distribution of coagulation factor IX products, which are used to treat bleeding disorders such as hemophilia B. As the coagulation factor ix market size is expected to witness significant growth, driven by the increasing prevalence of bleeding disorders and the growing demand for effective treatments, the growth outlook and market forecast are crucial for industry players. The industry expansion is anticipated to be driven by advancements in technology, changing regulatory landscapes, and shifting consumer behavior, making it essential for stakeholders to stay informed about the latest trends and developments in the coagulation factor IX market.

Loading chart…

The current coagulation factor IX market size is approximately $1.4 billion, with the global market expected to grow at a CAGR of 8.5% during the forecast period. The growth forecast is driven by macro drivers such as the increasing prevalence of bleeding disorders, advancements in technology, and the growing demand for effective treatments. Key forces shaping the industry include technology shifts, such as the development of gene therapies, regulations, such as the implementation of strict safety protocols, and competitive intensity, with multiple players competing for market share. The largest region in the coagulation factor IX market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the increasing awareness and adoption of coagulation factor IX products in the region.

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	3.94 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pfizer; CSL Behring; Grifols; Novo Nordisk; Bioverativ; Sanquin; Takeda; Baxter; Aptevo
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The coagulation factor ix market is poised for significant growth, driven by various factors that are reshaping the industry landscape. Understanding the dynamics of this market is crucial for stakeholders to make informed decisions and stay ahead of the competition.

Growth Drivers2 items

Increasing prevalence of hemophilia B, a condition that requires coagulation factor ix for treatment, is driving the demand for coagulation factor ix products, thereby contributing to the growth of the coagulation factor ix market size.

Advances in technology have led to the development of more effective and longer-acting coagulation factor ix products, which is expected to fuel the growth forecast of the market in the coming years.

Restraints2 items

High costs associated with the development and production of coagulation factor ix products are limiting their adoption in some regions, thereby restraining the growth of the coagulation factor ix market.

Stringent regulatory requirements and the need for rigorous clinical trials are also hindering the entry of new players into the market, which can impact the overall coagulation factor ix market size.

Opportunities2 items

Emerging economies with a large patient population and increasing healthcare expenditure offer significant opportunities for the growth of the coagulation factor ix market.

The development of novel coagulation factor ix products with improved efficacy and safety profiles can help companies to differentiate themselves and gain a competitive edge in the market, driving the growth forecast.

Challenges2 items

Ensuring the supply chain integrity and preventing the contamination of coagulation factor ix products are significant challenges that manufacturers must address to maintain the trust of patients and regulatory authorities, which is critical for the coagulation factor ix market size.

The coagulation factor ix market is also facing challenges related to reimbursement and pricing, as healthcare systems and payers are increasingly seeking to control costs and improve outcomes, which can impact the growth forecast.

Market Segmentation

Loading chart…

The coagulation factor ix market can be segmented based on application, which refers to the specific use of coagulation factor ix in various medical treatments. This segmentation category contributes significantly to the overall coagulation factor ix market size, as different applications have distinct demand patterns and growth prospects. Understanding the application-based segmentation is crucial for market players to develop targeted strategies and capitalize on emerging opportunities in the coagulation factor ix segmentation landscape.

Another key segmentation category in the coagulation factor ix market is types, which encompasses various subtypes such as recombinant coagulation factor ix and plasma-derived coagulation factor ix. Each subtype has its own set of characteristics, advantages, and limitations, influencing the market dynamics and growth trajectory. Analyzing the types-based segmentation is essential to comprehend the market taxonomy and identify areas of high potential for innovation and investment in the coagulation factor ix market.

coagulation factor ix Segmentation Breakdown6 items

Application

Adult

Kids

Types

Coagulation Factor IX (Plasma Derived)

Coagulation Factor IX (Recombinant)

Regional Insights

Loading chart…

The coagulation factor ix market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of coagulation factor ix products, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, increasing demand for coagulation factor ix products, and a high level of ecosystem maturity. Asia Pacific's growth is driven by a large and growing patient population, increasing healthcare expenditure, and rising awareness of bleeding disorders.

Latin America's coagulation factor ix market growth is expected to be driven by improving economic conditions, increasing access to healthcare, and a growing middle class. In the Middle East & Africa, key drivers include a growing patient population, increasing investment in healthcare infrastructure, and rising demand for coagulation factor ix products. The regional forecast indicates a positive outlook for the coagulation factor ix market, with opportunities for growth and expansion in emerging regions.

Competitive Landscape

The coagulation factor ix market is moderately consolidated, driven by a mix of global players and local companies. The coagulation factor ix competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must adapt to changing market dynamics and evolving customer needs.

Pfizer: regional expansion

CSL Behring: innovation pipeline

Grifols: vertical integration

Novo Nordisk: premium pricing

Bioverativ: OEM tie-ups

Sanquin: local manufacturing

Key coagulation factor ix Companies9 items

Pfizer

CSL Behring

Grifols

Novo Nordisk

Bioverativ

Sanquin

Takeda

Baxter

Aptevo

Market Ecosystem

The coagulation factor ix ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly divided into three stages: upstream, where raw materials and components are sourced; midstream, where these inputs are integrated into coagulation factor ix products; and downstream, where these products are distributed and consumed. Value is created and captured at each stage, with various participants playing distinct roles in the coagulation factor ix ecosystem.

Raw material/component suppliers — provide critical inputs

OEMs / manufacturers — produce coagulation factor ix products

Technology providers — develop innovative production methods

Distributors / channel partners — facilitate product delivery

Service providers / after-sales — offer support and maintenance

End users / buyers — purchase and use coagulation factor ix products

Regulators/standards bodies — establish and enforce safety standards

In the coagulation factor ix ecosystem, control points are primarily held by regulators and standards bodies, as well as by large OEMs and manufacturers. Dependency risks arise from input constraints, stringent regulatory approvals, and high switching costs. The ecosystem's structure and dynamics can also vary significantly by region, with different regions having distinct regulatory frameworks, market preferences, and competitive landscapes. A thorough value chain analysis is essential to understanding the intricacies of the coagulation factor ix ecosystem and identifying opportunities for growth and collaboration.

Recent Industry Insights

The coagulation factor ix industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have been forged to enhance research and development of novel coagulation factor IX products. Notable mergers and acquisitions have also taken place, aiming to expand product portfolios and strengthen market positions. Furthermore, several product and technology launches have been announced, focusing on improving the efficacy and safety of coagulation factor IX treatments.

Additionally, regulatory changes have been implemented to ensure stricter safety standards and more efficient approval processes for coagulation factor IX products. A shift in consumer trends has also been observed, with an increasing demand for more convenient and patient-centric treatment options. The industry has also seen notable funding rounds and expansions, supporting the development of innovative coagulation factor IX therapies and driving growth in the market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the coagulation factor ix market outlook. The market attractiveness is moderate, driven by the growing prevalence of hemophilia B and the increasing demand for effective treatments. The competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with the global coagulation factor ix market expected to grow significantly over the forecast period.

The innovation landscape is rapidly evolving, with a focus on developing novel and more effective treatments. However, the demand–supply balance is a key concern, with fluctuations in supply affecting the overall market. Key risk factors include regulatory changes, pricing pressure, and supply chain disruptions. Understanding these factors is crucial for decision-makers to navigate the coagulation factor ix market outlook and make informed strategic decisions.

12 items

1. Executive Summary

2. coagulation factor ix Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global coagulation factor ix Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global coagulation factor ix Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global coagulation factor ix Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global coagulation factor ix Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global coagulation factor ix Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global coagulation factor ix Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global coagulation factor ix Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global coagulation factor ix Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global coagulation factor ix Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global coagulation factor ix Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global coagulation factor ix Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global coagulation factor ix Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global coagulation factor ix Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global coagulation factor ix Market Competition by Key Manufacturers

9.1. Global coagulation factor ix Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global coagulation factor ix: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Pfizer

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. CSL Behring

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Grifols

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Novo Nordisk

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bioverativ

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Sanquin

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Takeda

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Baxter

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Aptevo

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global coagulation factor ix Market

Figure 4: Global coagulation factor ix Market: Drivers

Figure 5: Global coagulation factor ix Market: Challenges

Figure 6: Global coagulation factor ix Market: Trends

Figure 7: Global coagulation factor ix Market: Opportunity

Figure 8: Global coagulation factor ix Market: Restraint

Figure 9: Global coagulation factor ix Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global coagulation factor ix Market Value (USD Million) By Region

Figure 19: Global coagulation factor ix Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global coagulation factor ix Market Value (USD Million) By Region

Figure 27: Global coagulation factor ix Market Share (%) By: Regions (2032)

Figure 28: Global coagulation factor ix Market Volume (K) By Region

Figure 29: Global coagulation factor ix Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global coagulation factor ix Market Value (USD Million) By Region

Figure 37: Global coagulation factor ix Market Share (%) By: Regions (2032)

Figure 38: Global coagulation factor ix Market Volume (K) By Region

Figure 39: Global coagulation factor ix Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global coagulation factor ix Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global coagulation factor ix Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global coagulation factor ix Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global coagulation factor ix Market Value (USD Million) By Region

Table 14: Global coagulation factor ix Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global coagulation factor ix Market Volume (K) By Region

Table 31: Global coagulation factor ix Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global coagulation factor ix Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global coagulation factor ix Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global coagulation factor ix Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Pfizer Basic Information And Sales Area

Table 52: Pfizer. Products Portfolio

Table 53: CSL Behring Basic Information And Sales Area

Table 54: CSL Behring. Products Portfolio

Table 55: Grifols Basic Information And Sales Area

Table 56: Grifols. Products Portfolio

Table 57: Novo Nordisk Basic Information And Sales Area

Table 58: Novo Nordisk. Products Portfolio

Table 59: Bioverativ Basic Information And Sales Area

Table 60: Bioverativ. Products Portfolio

Table 61: Sanquin Basic Information And Sales Area

Table 62: Sanquin. Products Portfolio

Table 63: Takeda Basic Information And Sales Area

Table 64: Takeda. Products Portfolio

Table 65: Baxter Basic Information And Sales Area

Table 66: Baxter. Products Portfolio

Table 67: Aptevo Basic Information And Sales Area

Table 68: Aptevo. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global coagulation factor ix Market Value (USD Million) By Region

Table 78: Global coagulation factor ix Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global coagulation factor ix Market Volume (K) By Region

Table 95: Global coagulation factor ix Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

coagulation factor ix Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	3.94 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pfizer; CSL Behring; Grifols; Novo Nordisk; Bioverativ; Sanquin; Takeda; Baxter; Aptevo
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Emerging economies with a large patient population and increasing healthcare expenditure offer significant opportunities for the growth of the coagulation factor ix market.

Challenges2 items

Market Segmentation

Loading chart…

coagulation factor ix Segmentation Breakdown6 items

Application

Adult

Kids

Types

Coagulation Factor IX (Plasma Derived)

Coagulation Factor IX (Recombinant)

Regional Insights

Loading chart…

Competitive Landscape

Pfizer: regional expansion

CSL Behring: innovation pipeline

Grifols: vertical integration

Novo Nordisk: premium pricing

Bioverativ: OEM tie-ups

Sanquin: local manufacturing

Key coagulation factor ix Companies9 items

Pfizer

CSL Behring

Grifols

Novo Nordisk

Bioverativ

Sanquin

Takeda

Baxter

Aptevo

Market Ecosystem

Raw material/component suppliers — provide critical inputs

OEMs / manufacturers — produce coagulation factor ix products

Technology providers — develop innovative production methods

Distributors / channel partners — facilitate product delivery

Service providers / after-sales — offer support and maintenance

End users / buyers — purchase and use coagulation factor ix products

Regulators/standards bodies — establish and enforce safety standards

Recent Industry Insights

Analyst Overview

Table of Contents